The drug is also indicated for obesity-related to proopiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1), or leptin receptor (LEPR) deficiency. The gene discussed is PCSK1; the disease is obesity due to melanocortin 4 receptor deficiency.